Thoratec, A Bio Stock With Good Potential And ProductsSeeking AlphaHistorically, heart transplantation is one of the standard methods for approaching end-stage heart disease. But the market has significantly changed to alternative therapies such as the…
|
European Medicines Agency Validates Gilead’s Marketing Application for …
Business Wire (press release) Chronic HCV is a major cause of liver cancer and liver transplantation in Europe and around the world. The current standard of care for HCV involves 24-48 weeks of therapy with RBV and peg-IFN, which has to be injected and is associated with … |
Hospital conveys apologies to heart transplant patient and donor family7thSpace Interactive (press release)The incident involved a 58-year-old female patient with critical end-stage heart failure undergoing heart transplantation at Queen Mary Hospital …
Hepatitis C: A 21st Century Success Story (Op-Ed)LiveScience.comBut the condition can lead to the development of cirrhosis and liver cancer, and is the leading indication for liver transplantation in the United States. Baby boomers have the highest rat…
|
Government hospital refutes allegations on UK girl’s organ misuse
NDTV “Only renal transplantation is being conducted in Ludhiana, Jalandhar, Mohali and Chandigarh for which the donor and recipient are kept in the same operation theatre that too after an exhaustive matching tests and investigations for months together. |
Hospital extends apologies to heart transplant patient and donor family7thSpace Interactive (press release)The incident involved a 58-year-old female patient with critical end-stage heart failure undergoing heart transplantation at Queen Mary Hospital …
|
Gilead Hepatitis C Drug Gets Accelerated Review
Fox Business Chronic HCV is a major cause of liver cancer and liver transplantation in Europe and around the world, the company said. Chief Executive John C. Martin said that if approved, sofosbuvir has the potential to improve cure rates, while reducing the … EMA Approves MAA for Gilead’s (GILD) SofosbuvirStreetInsider.com (subscription) |
HeartWare Beating Away, Pulse Still StrongForbesApproximately 1 million patients suffer from Class IV heart failure, the most severe stage of the disease. Heart transplantation is a proven treatment option for Class IV heart failure patients, but a lim…
Hemoconcentration in ex vivo lung perfusion: A case report of a novel …The Journal of Thoracic and Cardiovascular SurgeryReconditioning of initially rejected donor lungs during ex vivo lung perfusion (EVLP) may increase the number of patients treated…
Hackensack restarts kidney transplantation programNJBIZHackensack University Medical Center announced it has reactivated its adult kidney transplantation program, with Dr. James Lim at the helm. The hospital announced it got approval from the Centers f…